lenalidomide has been researched along with Carcinoma, Renal Cell in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, R; Burris, HA; Fandi, A; Garcia, JA; Infante, JR; Jungnelius, U; Li, S; Redman, B; Rini, B | 1 |
| Amato, RJ; Hernandez-McClain, J; Khan, M; Saxena, S | 1 |
| Cooney, MM; Remick, SC; Vogelzang, NJ | 1 |
| Baz, RC; Bukowski, RM; Choueiri, TK; Dreicer, R; Elson, P; Garcia, JA; Jinks, HA; Mekhail, TM; Rini, BI; Thakkar, SG | 1 |
| Rivera, C; Stein, EM | 1 |
| Bacik, J; DeLuca, J; Ishill, N; Kondagunta, GV; Motzer, RJ; Patel, PH; Russo, P; Schwartz, L | 1 |
1 review(s) available for lenalidomide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Promising systemic therapy for renal cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Carcinoma, Renal Cell; Drug Administration Schedule; Epothilones; Erlotinib Hydrochloride; Humans; Indoles; Kidney Neoplasms; Lenalidomide; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thalidomide | 2005 |
4 trial(s) available for lenalidomide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Humans; Indoles; Kidney Neoplasms; Lenalidomide; Male; Maximum Tolerated Dose; Middle Aged; Pyrroles; Sunitinib; Thalidomide; Treatment Outcome | 2014 |
Lenalidomide therapy for metastatic renal cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Disease Progression; Disease-Free Survival; Fatigue; Female; Hematologic Diseases; Humans; Kidney Neoplasms; Lenalidomide; Male; Middle Aged; Survival Rate; Thalidomide | 2008 |
Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Immunologic Factors; Kidney Neoplasms; Lenalidomide; Male; Middle Aged; Neoplasm Metastasis; Thalidomide; Treatment Outcome | 2006 |
Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Lenalidomide; Male; Middle Aged; Neoplasm Metastasis; Thalidomide; Treatment Outcome | 2008 |
1 other study(ies) available for lenalidomide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Transient thyroiditis after treatment with lenalidomide in a patient with metastatic renal cell carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials, Phase I as Topic; Humans; Kidney Neoplasms; Lenalidomide; Male; Thalidomide; Thyroid Function Tests; Thyroiditis; Treatment Outcome | 2007 |